MEDICINES
LAB TESTS
CONSULT DOCTORS
CANCER CARE
AYURVEDA
PARTNERSHIPS
CARE PLAN
Login
|
Signup
Order Summary
0 Test
PROCEED TO CART
Need Help?
MEDICINES
LAB TESTS
DOCTORS
CANCER CARE
How can we help?
Home
CLPD Basic

CLPD Basic

Also referred as
Subtyping of Lymphoma and Chronic Lymphocytic Leukemia
Blood CLPD Characterization Panel
Leukemia Characterisation Panel for Chronic Lymphocytic Proliferative Disorders
+1
Chronic Lymphoproliferative Disorder ( CLPD ) Panel - By Flow Cytometry
For men & women
Earliest reports in
96 hours
Contains
1 test
Know more about this test

The CLPD Basic is a specialized test that helps identify disorders affecting lymphocytes, white blood cells that play a crucial role in the immune system. It detects changes that may indicate chronic lymphoproliferative disorders or leukemia, helping doctors diagnose, classify, and monitor the disease for accurate treatment planning.

Samples required
Blood
Find out
Why is this test booked?
Preparation for this test
Sample Collection
Who will collect your samples?

Understanding CLPD Basic

CLPD (Chronic Lymphoproliferative Disorder) is a group of disorders characterized by the abnormal growth of lymphocytes, a type of white blood cell that helps the body fight infections. In some cases, CLPD may progress into leukemia, a cancer of the blood and bone marrow. Early detection and precise classification are essential for proper management and treatment.

The CLPD Basic uses flow cytometry to analyze multiple cell surface markers, including CD5, CD10, CD19, CD20, CD23, CD38, FM7, Kappa, Lambda, CD100, and others. Each marker provides information about the type and maturity of lymphocytes, helping doctors identify different subtypes of leukemia or lymphoproliferative disorders.

Doctors may recommend the CLPD Basic test for CLPD, Blood for patients who show symptoms such as unexplained fatigue, fever, weight loss, or frequent infections, or when there is a suspicion of leukemia or another blood disorder. It is also advised for patients undergoing treatment for leukemia to monitor progress, assess treatment effectiveness, and track disease progression. This test helps doctors identify specific types of white blood cells, diagnose different forms of leukemia, and guide personalized management decisions, making it essential for individuals whose medical history, symptoms, or blood test results indicate a possible lymphoproliferative disorder or leukemia.

For this test, it is important to submit the clinical history, histopathology report, previous test results, and a doctor’s prescription at the time of sample collection. The Tata 1mg consolidated Test Requisition Form (TRF) must also be duly filled and submitted.

Lab test results may vary across different laboratories. Abnormal test results require an expert interpretation. Therefore, never try to self-medicate at home based solely on these results, and always consult a doctor for proper understanding of the test results.

See more

What does CLPD Basic measure?

The CLPD Basic measures multiple cell surface markers (antigens) on white blood cells to detect abnormal patterns in lymphocyte populations. It uses Flow Cytometry, a technique that evaluates the physical and chemical characteristics of cells in a fluid as they pass through lasers. This allows the test to determine the type of cells, their number, size, shape, and the presence of specific surface markers.

In the context of CLPD, Flow Cytometry helps identify whether the disorder involves B-cells, T-cells, or other lymphocyte types, and analyzes markers such as CD5, CD10, CD19, CD20, CD23, CD38, FM7, Kappa, Lambda, CD100, among others. These markers provide important information for classifying the type of lymphoproliferative disorder, assessing its aggressiveness, and differentiating between various forms of leukemia. By combining cell counts, physical characteristics, and marker expression, this test enables doctors to diagnose the disorder accurately, monitor treatment response, and guide personalized therapy decisions.

FAQs related to CLPD Basic

This test evaluates lymphocytes, a type of white blood cell, to detect chronic lymphoproliferative disorders (CLPDs) and classify different forms of leukemia. It helps doctors understand the type of blood disorder and plan appropriate treatment.
It is recommended for individuals who have abnormal blood counts, unexplained fatigue, recurrent infections, night sweats, or weight loss, or when a doctor suspects leukemia, lymphoma, or other blood disorders. It is also used to monitor treatment response in patients undergoing therapy for leukemia.
No fasting is needed for this test.
The test is generally safe. Minor risks include mild pain, bruising, or discomfort at the site of blood collection.
The test identifies the type and characteristics of lymphocytes. Abnormal results may indicate leukemia, lymphoma, or another blood-related disorder. Results help doctors classify the disorder, monitor disease progression, and guide treatment decisions.
The test uses Flow Cytometry to examine the physical and chemical characteristics of cells and detect cell surface markers that help classify B-cell, T-cell, or other lymphoproliferative disorders.
Yes. CLPDs are considered blood cancers because they involve uncontrolled growth of white blood cells.
Symptoms may include fatigue, fever, night sweats, weight loss, frequent infections, or enlarged lymph nodes. Some people may have no symptoms in early stages.
While there is no universal cure, treatment can control symptoms, slow disease progression, and improve quality of life. Some patients may receive targeted therapies, chemotherapy, or bone marrow transplantation depending on the subtype.
The test identifies the type of lymphocytes involved, classifies the disorder, monitors treatment response, and guides personalized therapy decisions.
Individuals with abnormal blood counts, suspected leukemia or lymphoma, or symptoms like unexplained fatigue and frequent infections may be advised to take the test.
Content created by
Written by:
Dr. Lipika Khurana
BDS, PGDHHM
Reviewed by:
Dr. Swati Gupta (Anand)
MBBS, MD Lab Medicine
Want to know moreRead our editorial policy
Last Updated11th Jan 2026

CLPD Basic test price for other cities

Price inFaridabadRs. 7315
Price inAllahabadRs. 7315
Price inChandigarhRs. 7315
Price inBangaloreRs. 7315
Price inBhopalRs. 7315

How does home sample collection work?

Easy online booking

Search for tests and packages, book your preferred time slot and enter your address for seamless at-home lab tests.

Live tracking of phlebotomist

Track our trained phlebotomist's real time location for seamless sample collection.

Safe Sample Collection

Our phlebotomists follow strict safety protocols to collect samples safely at home and on time.

Sample received at lab

Samples are transported securely to our accredited labs with world-class machines for testing by qualified experts.

Quick, Doctor-Verified Reports

Get doctor-approved reports via email and WhatsApp, with options for doctor follow-ups and AI insights.

Download the Tata 1mg app. Trusted healthcare, at your fingertips.

Book tests, track reports, and get AI-powered health insights.

or
Test conducted by
Core Diagnostics Private Limited
ISO, CAP, NABL certified
Know More
Contains 1 test
CLPD Basic